Hongwei D Yu Selected Research

Hongwei D Yu Research Topics

12	Infections 01/2022 - 04/2007
12	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 05/2007
2	Inflammation (Inflammations) 01/2021 - 04/2009
2	Pneumonia (Pneumonitis) 01/2019 - 03/2012
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Persistent Infection 03/2014
1	Starvation 01/2013
1	Disease Progression 04/2009
1	Necrosis 04/2007
1	Lung Injury 04/2007

10	AlginatesIBA 01/2020 - 05/2007
3	Sigma FactorIBA 01/2019 - 01/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2016
1	CarrageenanIBA 01/2021
1	OligosaccharidesIBA 01/2021
1	Rifaximin (L 105)FDA Link 01/2019
1	NitritesIBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2019
1	FluoroquinolonesIBA 02/2016
1	Biomarkers (Surrogate Marker)IBA 03/2014
1	Staphylococcal Protein A (Protein A)IBA 01/2013
1	Virulence Factors (Pathogenicity Factors)IBA 03/2012
1	Proteins (Proteins, Gene)FDA Link 04/2009
1	Phosphodiesterase 5 InhibitorsIBA 09/2007
1	Complement System Proteins (Complement)IBA 04/2007
1	InterleukinsIBA 04/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2007
1	AerosolsIBA 04/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007
1	CytokinesIBA 04/2007
1	Monocyte Chemoattractant ProteinsIBA 04/2007
1	Interleukin-17 (Interleukin 17)IBA 04/2007
1	Peroxidase (Myeloperoxidase)IBA 04/2007

1	Therapeutics 01/2022
1	Intraperitoneal Injections 01/2020